Viscos, LLC Launches New Product, Play Again™, at - WCIV-TV | ABC News 4 - Charleston News, Sports, Weather

Viscos, LLC Launches New Product, Play Again™, at

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact


Viscos, LLC, the maker of Play Again™, a premium, oral liquid for joint pain and discomfort.

Play Again is positioned to revolutionize this category of nutritional supplements for any age.

INDIANAPOLIS, Jan. 15, 2014 /PRNewswire/ -- Viscos, LLC announced today the launch of Play Again™, a clinically proven formula daily supplement for joint health, discomfort and recovery, on (NYSE: GNC), the nation's largest specialty retailer of health, wellness and sports nutrition products.  This launch expands availability to consumers of all ages who are actively looking for alternative pain management solutions, joint, ligament and tendon maintenance and long term preventative products. 

Play Again is a great tasting dietary supplement that is comprised of high molecular weight hyaluronic acid (HA) as the only active ingredient.  It is packaged in a 16 oz. bottle to consume 75mg to 225 mg daily as a replenishment of hyaluronic acid (HA), a naturally occurring molecule in the body.  HA is in the synovial fluid that coats and protects all the organs, connective tissues and joints.  HA provides hydration and cushioning.  Our formulation allows the HA to be quickly absorbed for bioavailability dispersed into the extra-cellular matrix throughout the entire body.  This formula is caffeine and gluten free, and contains zero carbs or calories.

In late 2011, Play Again was launched by Viscos, LLC in the Indianapolis market.  Shortly after launch, Play Again was quickly recognized by local orthopedic surgeons, sports medicine physicians, physical therapists and athletic trainers as an effective alternative for joint and connective tissue problems seen in their patients daily.  Viscos, LLC began a double-blind randomized clinical trial in early 2013, which is still ongoing, to obtain data for efficacy and safety of Play Again.  Debbie Ecksten, President states, "The importance of having this clinical data for medical professionals and consumers should be a priority for any manufacturer now more than ever.  This trial is the best decision we have made in the short life of our company.  There are many supplements in the market that provide claims without any strong clinical evidence." 

2013 ended as great growth for Viscos, LLC and Play Again.  Viscos, LLC market survey showed over 50% of purchasers of Play Again had a recommendation from a medical professional or an endorsement from a professional athlete.  Play Again has been become a daily supplement for many pro athletes.  Combined with our physician recommendations, rapidly developing social media penetration, increased use by athletes and active people of any age, Play Again is becoming the premium supplement in this category.  Viscos, LLC is receiving inquiries worldwide and looking forward to an international distribution by Q4 of 2014.

Ecksten states, "With GNC being an influential leader in health and wellness, we are honored for this opportunity to expose more consumers to this exceptional premium product."  Play Again is manufactured in a FDA approved pharmaceutical laboratory in the United States and retails for $49.95.  For more information please visit the website,

Media Contact 
Christy Newland

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow


888 Allbritton Dr.
Mt. Pleasant, SC 29464
843-881-4444 | Advertising Information

Public Information File

For assistance with accessing WCIV-TV's public information file, click here.


Advertising Credit Application and Terms and Conditions PDF.

Powered by WorldNow
All content Copyright © 2014 WCIV and Worldnow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.